Literature DB >> 20494105

Beyond the cell surface: new mechanisms of receptor function.

Carlos F Ibáñez1.   

Abstract

The text book view of cell surface receptors depicts them at the top of a vertical chain of command that starts with ligand binding and proceeds in a lineal fashion towards the cell nucleus. Although pedagogically useful, this view is incomplete and recent findings suggest that the extracellular domain of cell surface receptors can be a transmitter as much as a receiver in intercellular communication. GFRalpha1 is a GPI-anchored receptor for GDNF (glial cell line-derived neurotrophic factor), a neuronal growth factor with widespread functions in the developing and adult nervous system. GFRalpha1 partners with transmembrane proteins, such as the receptor tyrosine kinase RET or the cell adhesion molecule NCAM, for intracellular transmission of the GDNF signal. In addition to this canonical role, GFRalpha1 can also engage in horizontal interactions and thereby modify the function of other cell surface components. GFRalpha1 can also function as a ligand-induced adhesion cell molecule, mediating homophilic cell-cell interactions in response to GDNF. Finally, GFRalpha1 can also be released from the cell surface and act at a distance as a soluble factor together with its ligand. This plethora of unconventional mechanisms is likely to be a feature common to several other receptors and considerably expands our view of cell surface receptor function. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20494105     DOI: 10.1016/j.bbrc.2010.01.136

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

Review 1.  Opioid glycopeptide analgesics derived from endogenous enkephalins and endorphins.

Authors:  Yingxue Li; Mark R Lefever; Dhanasekaran Muthu; Jean M Bidlack; Edward J Bilsky; Robin Polt
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

2.  The RET G691S polymorphism is a germline variant in desmoplastic malignant melanoma.

Authors:  Jodie Barr; Carol M Amato; Steven E Robinson; Nicole Kounalakis; William A Robinson
Journal:  Melanoma Res       Date:  2012-02       Impact factor: 3.599

3.  Overlapping roles and collective requirement for the coreceptors GAS1, CDO, and BOC in SHH pathway function.

Authors:  Benjamin L Allen; Jane Y Song; Luisa Izzi; Irene W Althaus; Jong-Sun Kang; Frédéric Charron; Robert S Krauss; Andrew P McMahon
Journal:  Dev Cell       Date:  2011-06-14       Impact factor: 12.270

Review 4.  Neurobiology of the incubation of drug craving.

Authors:  Charles L Pickens; Mikko Airavaara; Florence Theberge; Sanya Fanous; Bruce T Hope; Yavin Shaham
Journal:  Trends Neurosci       Date:  2011-07-20       Impact factor: 13.837

5.  Agrin binds to the N-terminal region of Lrp4 protein and stimulates association between Lrp4 and the first immunoglobulin-like domain in muscle-specific kinase (MuSK).

Authors:  Wei Zhang; Anne-Sophie Coldefy; Stevan R Hubbard; Steven J Burden
Journal:  J Biol Chem       Date:  2011-10-03       Impact factor: 5.157

6.  Global expression profiling reveals gain-of-function oncogenic activity of a mutated thyroid hormone receptor in thyroid carcinogenesis.

Authors:  Changxue Lu; Alok Mishra; Yuelin J Zhu; Paul Meltzer; Sheue-Yann Cheng
Journal:  Am J Cancer Res       Date:  2011       Impact factor: 6.166

7.  Responses to glial cell line-derived neurotrophic factor change in mice as spermatogonial stem cells form progenitor spermatogonia which replicate and give rise to more differentiated progeny.

Authors:  Nicole Parker; Hayley Falk; Dolly Singh; Anthony Fidaleo; Benjamin Smith; Michael S Lopez; Kevan M Shokat; William W Wright
Journal:  Biol Reprod       Date:  2014-08-27       Impact factor: 4.285

8.  Receptor-mediated increase in rabies virus axonal transport.

Authors:  Shani Gluska; Stefan Finke; Eran Perlson
Journal:  Neural Regen Res       Date:  2015-06       Impact factor: 5.135

Review 9.  Neurotrophic factors for disease-modifying treatments of Parkinson's disease: gaps between basic science and clinical studies.

Authors:  Piotr Chmielarz; Mart Saarma
Journal:  Pharmacol Rep       Date:  2020-07-22       Impact factor: 3.024

Review 10.  Ischemic stroke and repair: current trends in research and tissue engineering treatments.

Authors:  Jian Wang; Wen Yang; Hongjian Xie; Yu Song; Yongkui Li; Lin Wang
Journal:  Regen Med Res       Date:  2014-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.